"Nimodipine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
| Descriptor ID |
D009553
|
| MeSH Number(s) |
D03.383.725.203.570 D03.383.725.547.570
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nimodipine".
Below are MeSH descriptors whose meaning is more specific than "Nimodipine".
This graph shows the total number of publications written about "Nimodipine" by people in this website by year, and whether "Nimodipine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nimodipine" by people in Profiles.
-
Crespo MJ, Rom?n M, Tirado G, Martins AH, Ferrer-Acosta Y, Martinez-Jimenez SM. Dantrolene Significantly Improves Cerebral Blood Flow in a Rat Model of Hemorrhagic Vasospasms. Pharmacology. 2023; 108(3):265-273.
-
Rom?n M, Garc?a L, Morales M, Crespo MJ. The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats. Sci Rep. 2021 05 10; 11(1):9852.
-
Rom?n M, Ram?rez JM, Morales M, Crespo MJ. Significant reduction of vascular reactivity with dantrolene and nimodipine in diabetic rats: a potential approach to cerebral vasospasm management in diabetes. Pharmacol Rep. 2020 Feb; 72(1):126-134.